Diagnostics Inspired, Target Discovery for Cancer Immunotherapy.
Pyxis utilizes its unique data and know-how of immune-tumor-stroma communication networks to identify patients that are likely to respond to immunotherapy and to discover new targets and drug combinations to treat those who do not.
CEO: Ori Choshen